This report provides long-term outcome data on the Perimount valve implanted in the mitral position in patients 65 years of age or less. The expected valve durability was 14.2 years, which compares favourably with other prosthetic valves.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Bioprosthetic Mitral Valve Replacement in Patients Aged 65 Years or Younger: Long-Term Outcomes With the Carpentier–Edwards PERIMOUNT Pericardial Valve
February 15, 2018
February 2, 2018
A brief note on the feasibility (or not) of RCT on surgery for mitral fibroelastic prolapse.
January 25, 2018
A large follow-up study comparing repair and replacement results and trends. Of particular interest to the UK and European readership is the page 113 discussion on the center of mitral excellence principle.
January 18, 2018
This clinical video depicts the use of premeasured and premade PTFE neochordae for minimally invasive mitral valve repair.